tirzepatide indications for Weight Loss What Is Tirzepatide Used for?
Description
Research results are inconsistent despite consistent protocol
In another study, a double-blind, parallel-group trial was conducted in 72 adults with obesity, randomized to once-weekly subcutaneous semaglutide or placebo for 20 weeks
MTEB: massive text embedding benchmark
The increasing demand has, in part, contributed to global shortages (Putka, 2023
Second, we focused on patients eligible for EVT
